Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman is battling rumors surrounding superintelligence and AGI (artificial general intelligence). Is ChatGPT ...
Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's ...
Sam Altman, the CEO of OpenAI, now says he is more confident of a fast AI takeoff. A fast AI takeoff is more possible than he ...
"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird ...
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
OpenAI CEO Sam Altman has made several predictions about where we're headed on AGI, superintelligence, agentic AI — and when ...
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...